MangoceuticalsMGRX
13F holders, Q3 2025 (September 30)11holders +1
4new positions
3sold out
$2.19avg. 13F price*
At the end of Q3 2025, 11 institutions reported holding Mangoceuticals Inc. (MGRX) in their 13F filings, up 1 from Q2 2025. 4 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($420K), Geode Capital Management, LLC ($193K) and Ackerman Capital Advisors, LLC ($76K).
- Company
- Mangoceuticals Inc.
- CUSIP
- 56270V205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $120K |
| Exits | 3 | $66K |
All 13F filers, Q2 2025 → Q3 2025: 125,802 shares bought and 43,496 shares sold, net +82,306 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Vanguard Group Inc. | 0.00% | Add +5.1% | 192,004 | $420K |
| Geode Capital Management, LLC | 0.00% | Add +232.0% | 87,974 | $193K |
| Ackerman Capital Advisors, LLC | 0.02% | No change | 34,500 | $76K |
| XTX Topco Ltd | 0.00% | New | 28,514 | $62K |
| Northern Trust Corp. | 0.00% | New | 18,957 | $42K |
| Sunbelt Securities, Inc. | 0.00% | New | 7,000 | $15K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,885 | $6K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 2,094 | $5K |
| Royal Bank of Canada | 0.00% | New | 451 | $1K |
| Bank of America Corp. | 0.00% | Add +8.0% | 176 | $386 |
| UBS Group AG | 0.00% | Reduce -96.2% | 3 | $7 |
"% of holder's portfolio" is MGRX's weight in each manager's 13F, not the share of Mangoceuticals Inc. the manager owns.